Comparative tissue concentration profiles of fentanyl and alfentanil in humans predicted from tissue/blood partition data obtained in rats.

No abstract is available for this paper.

• Publication year

  1990

• Venue

  Anesthesiology

• Publication date

  1990-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/00000542-199005000-00017PMID 2339802
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Definitions and applications of mean transit and residence times in reference to the two-compartment mammillary plasma clearance model.

  1988cited by this paper
• Alfentanil Pharmacokinetics and Metabolism in Humans

  1988cited by this paper
• Simultaneous determination of fentanyl and alfentanil in rat tissues by capillary column gas chromatography.

  1988cited by this paper
• Population pharmacokinetics of alfentanil: the average dose-plasma concentration relationship and interindividual variability in patients.

  1987cited by this paper
• Decreased fentanyl and alfentanil dose requirements with age. A simultaneous pharmacokinetic and pharmacodynamic evaluation.

  1987cited by this paper
• Pharmacokinetics of Fentanyl in Patients Undergoing Abdominal Aortic Surgery

  1986cited by this paper
• Lipid solubility, pharmacokinetics, and the EEG: are you better off today than you were four years ago?

  1985cited by this paper
• EEG quantitation of narcotic effect: the comparative pharmacodynamics of fentanyl and alfentanil.

  1985cited by this paper
• Identification and quantitative determination of fentanyl metabolites in patients by gas chromatography--mass spectrometry.

  1984cited by this paper
• Prediction of the volumes of distribution of basic drugs in humans based on data from animals

  1984cited by this paper
• Prediction of diazepam disposition in the rat and man by a physiologically based pharmacokinetic model

  1983cited by this paper
• Physiologically based pharmacokinetic modeling: principles and applications.

  1983cited by this paper
• Clinical Pharmacokinetics of Fentanyl and its Newer Derivatives

  1983cited by this paper
• Comparative pharmacokinetics of fentanyl and alfentanil.

  1982cited by this paper
• The uptake of fentanyl by erythrocytes

  1982cited by this paper
• Plasma protein binding and distribution of fentanyl, sufentanil, alfentanil and lofentanil in blood.

  1982cited by this paper
• Tissue Redistribution of Fentanyl and Termination of Its Effects in Rats

  1981cited by this paper
• Intravenous fentanyl kinetics

  1980cited by this paper
• Pharmacokinetics of fentanyl as a possible explanation for recurrence of respiratory depression.

  1979cited by this paper
• Some fundamental considerations of the applications of pharmacokinetics to cancer chemotherapy.

  1975cited by this paper
• The disposition of propranolol. 3. Decreased half-life and volume of distribution as a result of plasma binding in man, monkey, dog and rat.

  1973cited by this paper
• Relation between binding to plasma protein, apparent volume of distribution, and rate constants of disposition and elimination for chlorpromazine in three species

  1972cited by this paper

• QSAR-based physiologically based pharmacokinetic (PBPK) modeling for 34 fentanyl analogs: model validation, human pharmacokinetic prediction and abuse risk insights

  2025cites this paper
• Acute Biodistribution Comparison of Fentanyl and Morphine

  2024cites this paper
• Evaluation of the risk of human exposure to thiamethoxam by extrapolation from a toxicokinetic experiment in rats and literature data.

  2023cites this paper
• In Vivo Pharmacokinetic Analyses of Placental Transfer of Three Drugs of Different Physicochemical Properties in Pregnant Rats.

  2022cites this paper
• Atypical Fentanyl Transdermal Patch Consumption and Fatalities: Case Report and Literature Review

  2022cites this paper
• Predicting Maternal-Fetal Disposition of Fentanyl Following Intravenous and Epidural Administration Using Physiologically Based Pharmacokinetic Modeling

  2021influential citation
• Higher naloxone dosing in a quantitative systems pharmacology model that predicts naloxone-fentanyl competition at the opioid mu receptor level

  2020cites this paper
• Modelling the Fate of Chemicals in Humans Using a Lifetime Physiologically Based Pharmacokinetic (PBPK) Model in MERLIN-Expo

  2018cites this paper
• Development and validation of bioanalytical assay methods for fentanyl in human plasma

  2018influential citation
• Pharmacokinetics of a Novel, Transdermal Fentanyl Solution in Rhesus Macaques (Macaca mulatta).

  2017cites this paper
• Comparison of Plain Bupivacaine, Bupivacaine-Butorphanol Combination and Bupivacaine-Fentanyl Combination for Post Operative Epidural Analgesia - A Tertiary Care Teaching Centre Experience

  2017cites this paper
• An introduction to physiologically‐based pharmacokinetic models

  2016cites this paper
• Modelling ecological and human exposure to POPs in Venice lagoon - Part II: Quantitative uncertainty and sensitivity analysis in coupled exposure models.

  2016cites this paper
• Development of a correlation based and a decision tree based prediction algorithm for tissue to plasma partition coefficients

  2013cites this paper
• Evaluation of analgesic effect of two different doses of fentanyl in combination with bupivacaine for surgical site infiltration in cases of modified radical mastoidectomy: A double blind randomized study

  2013cites this paper
• Correlation-based prediction of tissue-to-plasma partition coefficients using readily available input parameters

  2013cites this paper
• EFFICACY OF WOUND INFILTRATION USING BUPIVACAINE VERSUS ROPIVACAINE ALONG WITH FENTANYL FOR POSTOPERATIVE ANALGESIA FOLLOWING ABDOMINAL HYSTERECTOMY UNDER SPINAL ANESTHESIA

  2013cites this paper
• Physiologically-based pharmacokinetic model for Fentanyl in support of the development of Provisional Advisory Levels.

  2013cites this paper
• Mild hypothermia decreases fentanyl and midazolam steady-state clearance in a rat model of cardiac arrest

  2012cites this paper
• Basic Pharmacologic Principles

  2011cites this paper
• Role of phosphatidylserine binding in tissue distribution of amine-containing basic compounds

  2011cites this paper
• Factors Predicting Requirement of High-dose Transdermal Fentanyl in Opioid Switching From Oral Morphine or Oxycodone in Patients With Cancer Pain

  2011cites this paper
• Fentanyl in postmortem forensic toxicology

  2010cites this paper
• Multiple Peaking Phenomena in Pharmacokinetic Disposition

  2010cites this paper
• Desflurane requirements for laryngeal mask airway insertion during inhalation induction

  2009cites this paper
• [Measurement of amount of fentanyl remaining in used patches: investigation of clinical factors affecting the remaining amounts in 4 patients].

  2008cites this paper
• The effect of altered physiological states on intravenous anesthetics.

  2008cites this paper
• Prediction of drug tissue to plasma concentration ratios using a measured volume of distribution in combination with lipophilicity.

  2008cites this paper
• The comparison of intravenous anesthesia with fentanyl versus alfentanill during oocyte retrieval for in vitro fertilization

  2008cites this paper
• Mechanism‐based PK/PD Modeling of the Respiratory Depressant Effect of Buprenorphine and Fentanyl in Healthy Volunteers

  2007cites this paper
• Pharmacokinetics of Fentanyl in Male and Female Rats after Intravenous Administration

  2007cites this paper
• Physiologically based pharmacokinetic modelling 2: predicting the tissue distribution of acids, very weak bases, neutrals and zwitterions.

  2006cites this paper
• P b a m a c o k i n e t i c s of Human Extraction Cerebral A Comparative Study on Sufentanil, Fentanyl, and Alfentanil in a Patient after Severe Head Injury

  2006cites this paper
• Lung Injury Induced by Major Burns does not Affect Fentanyl Clearance

  2005cites this paper
• Physiologically based pharmacokinetic modeling 1: predicting the tissue distribution of moderate-to-strong bases.

  2005cites this paper
• Effect of atorvastatin and fluvastatin on the metabolism of midazolam by cytochrome P450 in vitro *

  2005cites this paper
• Recirculatory model of fentanyl disposition with the brain as the target organ.

  2004cites this paper
• Reduction and Lumping of Physiologically Based Pharmacokinetic Models: Prediction of the Disposition of Fentanyl and Pethidine in Humans by Successively Simplified Models

  2003cites this paper
• Prediction of the volume of distribution of a drug: which tissue‐plasma partition coefficients are needed?

  2002cites this paper
• Prediction of pharmacokinetics prior to in vivo studies. 1. Mechanism-based prediction of volume of distribution.

  2002cites this paper
• Prediction of the disposition of midazolam in surgical patients by a physiologically based pharmacokinetic model.

  2001cites this paper
• A Whole-Body Physiologically Based Pharmacokinetic Model Incorporating Dispersion Concepts: Short and Long Time Characteristics

  2001cites this paper
• Quantitative analysis of fentanyl in rat plasma by gas chromatography with nitrogen-phosphorus detection.

  2001cites this paper
• Clearance of Fentanyl, Alfentanil, Methohexitone, Thiopentone and Ketamine in Relation to Estimated Hepatic Blood Flow in Several Animal Species: Application to Prediction of Clearance in Man

  2000cites this paper
• A priori prediction of tissue:plasma partition coefficients of drugs to facilitate the use of physiologically-based pharmacokinetic models in drug discovery.

  2000cites this paper
• Pharmacokinetics of Human Cerebral Opioid Extraction: A Comparative Study on Sufentanil, Fentanyl, and Alfentanil in a Patient after Severe Head Injury

  2000cites this paper
• Fentanyl inhibits metabolism of midazolam: competitive inhibition of CYP3A4 in vitro.

  1999cites this paper
• Optimization of antitumor effect of liposomally encapsulated doxorubicin based on simulations by pharmacokinetic/pharmacodynamic modeling.

  1999cites this paper
• Steady-state propofol brain:plasma and brain:blood partition coefficients and the effect-site equilibration paradox.

  1998cites this paper
• The Peripheral Effect of Fentanyl on Postoperative Pain

  1998cites this paper
• Application of Physiologic Models to Predict the Influence of Changes in Body Composition and Blood Flows on the Pharmacokinetics of Fentanyl and Alfentanil in Patients

  1998cites this paper
• Transdermal delivery of fentanyl: rapid onset of analgesia using skin electroporation.

  1998cites this paper
• A Physiologically Based Pharmacokinetic Model Incorporating Dispersion Principles to Describe Solute Distribution in the Perfused Rat Hindlimb Preparation

  1997influential citation
• Pharmacokinetic-pharmacodynamic modelling of the EEG effect of alfentanil in rats.

  1997cites this paper
• Influence of continuous levels of fentanyl in rats on the mu-opioid receptor in the central nervous system.

  1997cites this paper
• A physiologically based pharmacokinetic model of zidovudine (AZT) in the mouse: model development and scale-up to humans.

  1997cites this paper
• [Principles of pharmacology].

  1997cites this paper
• Grundlagen der Pharmakologie

  1997cites this paper
• The Impact of Arteriovenous Concentration Differences on Pharmacodynamic Parameter Estimates

  1997cites this paper
• Determination of subnanogram concentrations of fentanyl in plasma by gas chromatography-mass spectrometry: comparison with standard radioimmunoassay.

  1997cites this paper
• Influence of Escherichia coli endotoxin on the pharmacokinetics and respiratory depressant effect of alfentanil in rabbits.

  1996cites this paper
• Use of parallel erlang density functions to analyze first-pass pulmonary uptake of multiple indicators in dogs

  1996cites this paper
• Determination of the steady state tissue distribution of midazolam in the rat.

  1996cites this paper
• Scaling basic toxicokinetic parameters from rat to man.

  1996cites this paper
• Discrepancies in pharmacokinetic parameter estimation between bolus and infusion studies in the perfused rat hindlimb

  1995cites this paper
• Pharmacodynamic model for acute tolerance development to the electroencephalographic effects of alfentanil in the rat.

  1995cites this paper
• Open loop control of multiple drug effects in anesthesia

  1995cites this paper
• Comparative physiological pharmacokinetics of fentanyl and alfentanil in rats and humans based on parametric single-tissue models

  1994cites this paper
• The hybrid model: a new pharmacokinetic model for computer-controlled infusion pumps

  1994cites this paper
• Tissue distribution of fentanyl and alfentanil in the rat cannot be described by a blood flow limited model

  1993cites this paper
• Dose-response effect of intrathecal alfentanil on canine lower urinary tract dynamics.

  1993cites this paper
• Determination of thalidomide in plasma and blood by high-performance liquid chromatography: avoiding hydrolytic degradation.

  1992cites this paper
• Pharmacodynamic modeling of anesthetic EEG drug effects.

  1992cites this paper
• Alfentanil infusion for postoperative pain: a comparison of epidural and intravenous routes.

  1991cites this paper
• Pharmacokinetics of opioid agonists and antagonists

  1991cites this paper
• Pharmacokinetics of Fentanyl

  1991cites this paper